nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse Events During Hematopoietic Stem Cell Infusion: Analysis of the Infusion Product
|
Vidula, Neelima |
|
2015 |
15 |
11 |
p. e157-e162 nvt p. |
artikel |
2 |
A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma
|
Lee, Jung-Hee |
|
2015 |
15 |
11 |
p. 655-663 9 p. |
artikel |
3 |
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
|
Flowers, Christopher R. |
|
2015 |
15 |
11 |
p. 694-698 5 p. |
artikel |
4 |
CD38 Monoclonal Antibody Therapies for Multiple Myeloma
|
Wong, Sandy W. |
|
2015 |
15 |
11 |
p. 635-645 11 p. |
artikel |
5 |
Collateral Circulation Resulting From Obstruction Due to Cardiac Lymphoma of Right Atrium
|
Riccioli, Vincenzo |
|
2015 |
15 |
11 |
p. e173-e176 nvt p. |
artikel |
6 |
Economic Burden of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia
|
Knopf, Kevin B. |
|
2015 |
15 |
11 |
p. e163-e171 nvt p. |
artikel |
7 |
Editorial Board/Masthead
|
|
|
2015 |
15 |
11 |
p. A1- 1 p. |
artikel |
8 |
Effect of Red Blood Cell Transfusion Dependence on the Natural History of Myeloproliferative Neoplasm-Associated Myelofibrosis
|
Bartoszko, Justyna |
|
2015 |
15 |
11 |
p. e151-e156 nvt p. |
artikel |
9 |
How Center Volumes Affect Early Outcomes in Acute Myeloid Leukemia
|
Hahn, Andrew W. |
|
2015 |
15 |
11 |
p. 646-654 9 p. |
artikel |
10 |
Impact of Alemtuzumab Therapy and Route of Administration in T-Prolymphocytic Leukemia: A Single-Center Experience
|
Damlaj, Moussab |
|
2015 |
15 |
11 |
p. 699-704 6 p. |
artikel |
11 |
Lenalidomide Treatment for Lower Risk Nondeletion 5q Myelodysplastic Syndromes Patients Yields Higher Response Rates When Used Before Azacitidine
|
Zeidan, Amer M. |
|
2015 |
15 |
11 |
p. 705-710 6 p. |
artikel |
12 |
Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective
|
Owen, Carolyn |
|
2015 |
15 |
11 |
p. 627-634.e5 6.3399374E7 p. |
artikel |
13 |
Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease
|
Reddy, Jay P. |
|
2015 |
15 |
11 |
p. 664-670.e2 66337 p. |
artikel |
14 |
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation
|
Kazmi, Syed M. |
|
2015 |
15 |
11 |
p. 687-693 7 p. |
artikel |
15 |
Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma
|
Adams, Hugo J.A. |
|
2015 |
15 |
11 |
p. 671-679 9 p. |
artikel |
16 |
Relationship Between Carfilzomib Dose and Efficacy Outcomes in Patients With Relapsed and/or Refractory Multiple Myeloma
|
Squifflet, Pierre |
|
2015 |
15 |
11 |
p. 680-686 7 p. |
artikel |
17 |
Table of Contents
|
|
|
2015 |
15 |
11 |
p. A12-A13 nvt p. |
artikel |
18 |
Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria
|
Aschauer, Gregor |
|
2015 |
15 |
11 |
p. e143-e149 nvt p. |
artikel |